66 related articles for article (PubMed ID: 15693088)
1. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
[TBL] [Abstract][Full Text] [Related]
2. Alterations in peripheral T- and B-cell subsets in patients with systemic sclerosis.
Wu J; Zhang X; Lin S; Wei Q; Lin Z; Jin O; Gu J
Int J Rheum Dis; 2024 Apr; 27(4):e15145. PubMed ID: 38661314
[TBL] [Abstract][Full Text] [Related]
3. CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion.
Papadimitriou TI; Singh P; van Caam A; Walgreen B; Gorris MAJ; Vitters EL; van Ingen IL; Koenders MI; Smeets RL; Vonk M; de Vries JM; van der Kraan PM; van Oosterhout Y; Huynen MA; Koenen HJPM; Thurlings RM
Ann Rheum Dis; 2024 Mar; 83(4):488-498. PubMed ID: 38123919
[TBL] [Abstract][Full Text] [Related]
4. Impaired immune function in children with Fanconi anaemia.
Myers KC; Bleesing JJ; Davies SM; Zhang X; Martin LJ; Mueller R; Harris RE; Filipovich AH; Kovacic MB; Wells SI; Mehta PA
Br J Haematol; 2011 Jul; 154(2):234-40. PubMed ID: 21542827
[TBL] [Abstract][Full Text] [Related]
5. Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.
Takeshita M; Suzuki K; Kondo Y; Morita R; Okuzono Y; Koga K; Kassai Y; Gamo K; Takiguchi M; Kurisu R; Mototani H; Ebisuno Y; Yoshimura A; Takeuchi T
Ann Rheum Dis; 2019 Oct; 78(10):1346-1356. PubMed ID: 31167762
[TBL] [Abstract][Full Text] [Related]
6. Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus.
Tang S; Wang Y; Ma X; Xiang X; Zhou X; Li Y; Jia Y; Hu F; Li Y
Clin Rheumatol; 2023 May; 42(5):1435-1442. PubMed ID: 36629999
[TBL] [Abstract][Full Text] [Related]
7. Identification of Crucial Hub Genes and Differential T Cell Infiltration in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Strategies.
Yang X; Wang C; Lin Y; Zhang P
Front Mol Biosci; 2022; 9():800888. PubMed ID: 35127829
[No Abstract] [Full Text] [Related]
8. Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Shah A; Storek J; Woolson R; Pinckney A; Keyes-Elstein L; Wallace PK; Sempowski GD; McSweeney P; Mayes MD; Crofford L; Csuka ME; Phillips K; Khanna D; Simms R; Ballen K; LeClercq S; Clair WS; Nixon AB; Nash R; Wener M; Brasington R; Silver R; Griffith LM; Furst DE; Goldmuntz E; Sullivan KM
Rheumatology (Oxford); 2022 Oct; 61(10):4155-4162. PubMed ID: 35108379
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Fröhlich M; Portegys J; Strunz PP; Schmalzing M
Rheumatol Int; 2022 Aug; 42(8):1373-1381. PubMed ID: 34694439
[TBL] [Abstract][Full Text] [Related]
10. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
[TBL] [Abstract][Full Text] [Related]
11. The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases.
Bank I
Cells; 2020 Feb; 9(2):. PubMed ID: 32085540
[TBL] [Abstract][Full Text] [Related]
12. Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome.
Rizzo C; La Barbera L; Lo Pizzo M; Ciccia F; Sireci G; Guggino G
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683641
[TBL] [Abstract][Full Text] [Related]
13. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.
Pecher AC; Kettemann F; Asteriti E; Schmid H; Duerr-Stoerzer S; Keppeler H; Henes JC; Klein R; Hinterleitner C; Secker KA; Schneidawind C; Kanz L; Schneidawind D
Arthritis Res Ther; 2019 Oct; 21(1):212. PubMed ID: 31615552
[TBL] [Abstract][Full Text] [Related]
14. Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.
Gumkowska-Sroka O; Jagoda K; Owczarek A; Helbig G; Giemza-Stokłosa J; Kotyla PJ
J Clin Med; 2019 May; 8(5):. PubMed ID: 31071980
[TBL] [Abstract][Full Text] [Related]
15. The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.
Baglaenko Y; Chang NH; Johnson SR; Hafiz W; Manion K; Ferri D; Noamani B; Bonilla D; Rusta-Sellehy S; Lisnevskaia L; Silverman E; Bookman A; Landolt-Marticorena C; Wither J
Arthritis Res Ther; 2018 Nov; 20(1):264. PubMed ID: 30486869
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to killer cell immunoglobulin-like receptor 3DL1 in patients with systemic lupus erythematosus.
Doi A; Kano S; Asano M; Takahashi Y; Mimori T; Mimori A; Kaneko H
Clin Exp Immunol; 2019 Mar; 195(3):358-363. PubMed ID: 30421793
[TBL] [Abstract][Full Text] [Related]
17. Integration of Genome-Wide DNA Methylation and Transcription Uncovered Aberrant Methylation-Regulated Genes and Pathways in the Peripheral Blood Mononuclear Cells of Systemic Sclerosis.
Zhu H; Zhu C; Mi W; Chen T; Zhao H; Zuo X; Luo H; Li QZ
Int J Rheumatol; 2018; 2018():7342472. PubMed ID: 30245726
[No Abstract] [Full Text] [Related]
18. Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.
Benyamine A; Magalon J; Sabatier F; Lyonnet L; Robert S; Dumoulin C; Morange S; Mazodier K; Kaplanski G; Reynaud-Gaubert M; Rossi P; Dignat-George F; Granel B; Paul P
Front Immunol; 2018; 9():1665. PubMed ID: 30072999
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
Front Immunol; 2018; 9():753. PubMed ID: 29706966
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
